Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Tables)

v2.4.0.6
Subsequent Events (Tables)
3 Months Ended
Jun. 30, 2012
Subsequent Events [Abstract]  
Schedule of Pro Forma Consolidated Results
The following table represents the unaudited pro forma consolidated results for the three months ended June 30, 2012 and 2011 as though the acquisition had occurred as of the beginning of the comparable prior annual reporting period.  The pro forma data includes CollabRx revenue of $13 and $1 for each of the respective periods.

   
PRO FORMA
 
   
Three Months Ended
 
   
June 30,
 
   
2012
   
2011
 
             
Loss from continuing operations
    (1,246 )     (1,381 )
                 
Loss from discontinued operations, net of taxes
    (1 )     (2 )
                 
Net loss applicable to common stockholders
    (1,247 )     (1,383 )
Basic and diluted:
               
Weighted-average common shares outstanding
    1,689       1,689  
                 
Net loss per share:
               
Basic and diluted
  $ (0.74 )   $ (0.82 )